Interleukin-24 inhibits the phenotype and tumorigenicity of cancer stem cell in osteosarcoma via downregulation Notch and Wnt/β-catenin signaling
Open Access
- 3 November 2021
- journal article
- research article
- Published by Elsevier in Journal of Bone Oncology
- Vol. 31, 100403
Abstract
No abstract availableKeywords
Funding Information
- Jiangsu Provincial Medical Youth Talent (QNRC2016373)
- National Natural Science Foundation of China (81972511)
This publication has 29 references indexed in Scilit:
- Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell lineBMC Cancer, 2012
- EXPRESSION, PURIFICATION, AND CHARACTERIZATION OF RGD-mda-7, A HIS-TAGGED mda-7/IL-24 MUTANT PROTEINJournal of Immunoassay and Immunochemistry, 2012
- Wnt Inhibitor Screen Reveals Iron Dependence of β-Catenin Signaling in CancersCancer Research, 2011
- Characterization of stem cell attributes in human osteosarcoma cell linesCancer Biology & Therapy, 2009
- Autocrine regulation of mda -7/IL-24 mediates cancer-specific apoptosisProceedings of the National Academy of Sciences, 2008
- Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and AngiogenesisJournal of Clinical Oncology, 2008
- Isolation and characterisation of cancer stem cells from canine osteosarcomaThe Veterinary Journal, 2008
- Intratumoral Injection of INGN 241, a Nonreplicating Adenovector Expressing the Melanoma-Differentiation Associated Gene-7 (mda-7/IL24): Biologic Outcome in Advanced Cancer PatientsMolecular Therapy, 2005
- Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I studyMolecular Therapy, 2005
- Interleukin-10andRelatedCytokines andReceptorsAnnual Review of Immunology, 2004